Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status
2019; Springer Science+Business Media; Volume: 21; Issue: 12 Linguagem: Inglês
10.1007/s12094-019-02154-3
ISSN1699-3055
AutoresCarmen Carriles, Paula Jiménez‐Fonseca, Manuel Sánchez-Cánovas, P. Pimentel, Alberto Carmona‐Bayonas, Teresa García, Mónica Carbajales-Álvarez, Ana Lozano-Blázquez,
Tópico(s)Colorectal and Anal Carcinomas
Referência(s)